Home LiteratureArticle Details
PMID: 20920372 Published · epublish English Journal Article Research Support, N.I.H., Intramural

Increased matrix metalloproteinase activation in esophageal squamous cell carcinoma.

Journal of translational medicine ·Vol. 8 ·2010-10-05 ·Pages 91

Mukherjee S, Roth MJ, Dawsey SM, Yan W, Rodriguez-Canales J, Erickson HS, Hu N, Goldstein AM, Taylor PR, Richardson AM, Tangrea MA, Chuaqui RF, Emmert-Buck MR

Abstract

Esophageal squamous cell carcinomas (ESCC) are usually asymptomatic and go undetected until they are incurable. Cytological screening is one strategy to detect ESCC at an early stage and has shown promise in previous studies, although improvement in sensitivity and specificity are needed. Proteases modulate cancer progression by facilitating tumor invasion and metastasis. In the current study, matrix metalloproteinases (MMPs) were studied in a search for new early detection markers for ESCC. Protein expression levels of MMPs were measured using zymography in 24 cases of paired normal esophagus and ESCC, and in the tumor-associated stroma and tumor epithelium in one sample after laser capture microdissection (LCM). MMP-3 and MMP-10 transcripts in both the epithelium and stroma in five cases were further analyzed by quantitative reverse transcriptase polymerase chain reaction (qRT-PCR). Gelatin zymography showed bands corresponding in size to MMP-2, MMP-3, MMP-9, and MMP-10 enzymes in each of the 24 cancer cases. MMP levels tended to be higher in tumors than paired normal tissue; however, only the 45 kDa band that corresponds to the activated form of MMP-3 and MMP-10 was strongly expressed in all 24 tumors with little or no expression in the paired normal foci. LCM-based analysis showed the 45 kDA band to be present in both the stromal and epithelial components of the tumor microenvironment, and that MMP-3 and MMP-10 mRNA levels were higher in tumors than paired normal tissues for each compartment. Increased levels of MMPs occur in ESCC suggesting their up-regulation is important in esophageal tumorigenesis. The up-regulated gene products have the potential to serve as early detection markers in the clinic.

MeSH Terms
Adult Aged Carcinoma, Squamous Cell/enzymology,pathology Enzyme Activation Esophageal Neoplasms/enzymology,pathology Female Humans Male Matrix Metalloproteinases/metabolism Middle Aged Polymerase Chain Reaction
Chemicals
Matrix Metalloproteinases
Authors & Affiliations
13 authors, click to expand affiliations / ORCID
Mukherjee Sumana
Pathogenetics Unit, Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Roth Mark J
Dawsey Sanford M
Yan Wusheng
Rodriguez-Canales Jaime
Erickson Heidi S
Hu Nan
Goldstein Alisa M
Taylor Philip R
Richardson Annely M
Tangrea Michael A
Chuaqui Rodrigo F
Emmert-Buck Michael R
References (21)
21 references, click to expand
  1. How matrix metalloproteinases regulate cell behavior.
    Annu Rev Cell Dev Biol. 2001;17:463-516 PMID: 11687497
  2. Stromelysin-2 overexpression in human esophageal squamous cell carcinoma: potential clinical implications.
    Cancer Detect Prev. 2002;26(3):222-8 PMID: 12269770
  3. [Liquid-based cytology for esophageal carcinoma screening].
    Ai Zheng. 2009 Dec;28(12):1243-7 PMID: 19958616
  4. Age- and gender-dependent changes in connective tissue remodeling: physiological differences in circulating MMP-3, MMP-10, TIMP-1 and TIMP-2 level.
    Gerontology. 2011;57(1):44-52 PMID: 20215736
  5. Increased expression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma.
    J Cancer Res Clin Oncol. 2004 Jan;130(1):37-44 PMID: 14569466
  6. Matrix metalloproteinases as modulators of inflammation and innate immunity.
    Nat Rev Immunol. 2004 Aug;4(8):617-29 PMID: 15286728
  7. Assessment of normalization strategies for quantitative RT-PCR using microdissected tissue samples.
    Lab Invest. 2007 Sep;87(9):951-62 PMID: 17643124
  8. New functions for the matrix metalloproteinases in cancer progression.
    Nat Rev Cancer. 2002 Mar;2(3):161-74 PMID: 11990853
  9. Cytologic detection of esophageal squamous cell carcinoma and its precursor lesions using balloon samplers and liquid-based cytology in asymptomatic adults in Llinxian, China.
    Acta Cytol. 2008 Jan-Feb;52(1):14-23 PMID: 18323271
  10. Matrix metalloproteinases, angiogenesis, and cancer: commentary re: A. C. Lockhart et al., Reduction of wound angiogenesis in patients treated with BMS-275291, a broad spectrum matrix metalloproteinase inhibitor. Clin. Cancer Res., 9: 00-00, 2003.
    Clin Cancer Res. 2003 Feb;9(2):551-4 PMID: 12576417
  11. Clinical significance of changes in tumor markers, extracellular matrix, MMP-9 and VEGF in patients with gastric carcinoma.
    Hepatogastroenterology. 2007 Jul-Aug;54(77):1591-5 PMID: 17708308
  12. Overexpression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma.
    Dis Esophagus. 2009;22(8):664-7 PMID: 19191857
  13. Mortality and incidence trends from esophagus cancer in selected geographic areas of China circa 1970-90.
    Int J Cancer. 2002 Nov 20;102(3):271-4 PMID: 12397650
  14. CD147 and matrix metalloproteinase-2 protein expression as significant prognostic factors in esophageal squamous cell carcinoma.
    Cancer. 2004 Nov 1;101(9):1994-2000 PMID: 15372476
  15. Production of matrix metalloproteinase-2 and metalloproteinase-3 related to malignant behavior of esophageal carcinoma. A clinicopathologic study.
    Cancer. 1992 Dec 15;70(12):2747-53 PMID: 1451050
  16. Matrix metalloproteinases expression correlates with survival in patients with esophageal squamous cell carcinoma.
    Am J Gastroenterol. 2005 Aug;100(8):1835-43 PMID: 16086722
  17. Value of endoscopic methylene blue and Lugol's iodine double staining and detection of GST-Pi and telomerase in the early diagnosis of esophageal carcinoma.
    World J Gastroenterol. 2005 Oct 21;11(39):6090-5 PMID: 16273632
  18. Global cancer statistics, 2002.
    CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108 PMID: 15761078
  19. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.
    Circ Res. 2003 May 2;92(8):827-39 PMID: 12730128
  20. Expression of activated gelatinase in human invasive breast carcinoma.
    Clin Exp Metastasis. 1993 Mar;11(2):183-9 PMID: 8444010
  21. Regulation of matrix metalloproteinase expression in tumor invasion.
    FASEB J. 1999 May;13(8):781-92 PMID: 10224222
Article Info
Journal
Journal of translational medicine
Abbr.
J Transl Med
ISSN
1479-5876
Published
2010-10-05
Epub
2010-00-05
Pages
91
Language
English
Region
England
NLM ID
101190741
PMCID
PMC2958908
Subset
IM
Grants
Intramural NIH HHS · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]